The global enteral feeding formulas market size was valued at USD 5.89 billion in 2020 and is projected to reach USD 9.21 billion by 2028, expanding at a CAGR of 5.7% during the forecast period, 2021–2028. The growth of the market is attributed to the increasing prevalence of chronic diseases such as stroke, chronic liver disease, multiple sclerosis, chronic obstructive pulmonary disease, dementia diabetes, and cancer along with the increasing demand for substitutes that support patients with oral intake issues.
Enteral feeding formulas are enteral feeding tubes for nutritional liquids that support diet of patients. The wide availability of product portfolio and product developments play a crucial role for positively influencing the market growth. Tube feed, ready-to-use nutritional supplements, and ready-to-drink are product categories, which consist a major market share over the years. The risk of malnutrition in the geriatric population and the extreme consequences of health conditions such as stroke, diabetes, depression, and dementia are key aspect of the market. This sometimes reduces the ability to carry out or perform normal activities of daily life, therewith increasing the risk of injuries or falls. Consequently, it is important to research the pathophysiology behind the situation, mainly, nutritional deficiency. The increasing pervasiveness of conditions such as malnutrition and anemia is likely to fuel the acceptance of enteral feeding formulas during the forecast period. According to a report by The Lancet published in 2020, over 31% people globally were affected with anemia.
The rising number of COVID-19 cases in different geographies with a huge geriatric population, ingenuous to various health conditions, are among the major factors contributing to the growth of the market. Additionally, weakened health and immunity due to polymorbidity increase the severity of COVID-19 in the geriatric population. This is attributed to rise the acceptance of enteral feeding formulas and processes. According to a report in Europe PMC in 2020, COVID-19 patients admitted to the ICUs prefer enteral nutrition instead of parenteral nutrition.
Market Trends, Drivers, Restraints, and Opportunities
- Rising chronic diseases listing cancer, stroke, multiple sclerosis, dementia, chronic liver disease is attributed to drive the demand for products supporting oral intake for patients. This is expected to fuel the market.
- Increasing cases of pre-matured births and rising prevalence of chronic illness among adults are key salient factors fueling the demand for enteral feeding formulas.
- Launching of new products and extensive availability of feeding formulas in retail shops are key factors significantly impacting the growth of the market.
- For post-surgery recovery, the demand for home health products is increasing and growing inclination towards easy methods for feeding are boosting the market growth.
- Technology developments and innovations in products and substitutes are other key factors driving market growth.
- Less understanding and awareness in respect to healthcare products and clinical nutrition are major challenges expected to limit the market growth.
Scope of the Report
The report on the global enteral feeding formulas market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes
|
Details
|
|
Report Title
|
Enteral Feeding Formulas Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast
|
|
Base Year
|
2020
|
|
Historic Data
|
2018–2019
|
|
Forecast Period
|
2021–2028
|
|
Segmentation
|
Products (Standard Formula and Disease-specific Formula), Flow Types (Intermittent Feeding Flow and Continuous Feeding Flow), Stages (Adult and Pediatric), Indications (Cancer Care, Nutrition Deficiency, Diabetes, Orphan Diseases, Dysphagia, Pain Management, Chronic Kidney Diseases, Malabsorption/Gi Disorder/Diarrhea, Alzheimer’s, and Others), End-users (Hospitals [Cardiology, Neurology, Critical Care, Oncology, and Others] and Home Care)
|
|
Regional Scope
|
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa
|
|
Report Coverage
|
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast
|
|
Key Players Covered in the Report
|
Abbott; Danone SA; Fresenius SE & Co. KGaA; Nestlé; Victus, Inc.; Primus Pharmaceuticals, Inc.; Meiji Holdings. Co., Ltd.; and Rickett Benckiser Group Plc.
|
Market Segment Insights
Standard formula segment is expected to grow at a rapid pace
Based on products, the global enteral feeding formulas market is bifurcated into standard formula and disease-specific formula. The standard formula segment accounted for a key share of the market in 2020 and is expected to grow at a rapid pace in the coming years owing to the availability of variety of formulas and increased demand for low cost formulas. However, the disease-specific formula segment is anticipated to expand at a significant growth rate during the forecast period due to recent product innovations for specific nutritional requirements.
Intermittent feeding flow segment is projected to expand at a considerable CAGR
On the basis of flow types, the market is bifurcated into intermittent feeding flow and continuous feeding flow. The Intermittent feeding flow segment is projected to expand at a considerable CAGR during the forecast period due to increase in adoption by hospitals for nutritional requirements of patients. However, the continuous feeding flow segment is expected to account for a key market share during the forecast period owing to rising prevalence of demand for oral intake of patients suffering from various diseases.
Adult segment is expected to expand at a robust growth rate
Based on stages, the global enteral feeding formulas market is divided into adult and pediatric. The adult segment is expected to expand at a robust growth rate during the projected period due to rise in acceptance of feeding tubes for critical incidences. On the other hand, the pediatric segment is anticipated to grow significantly during the forecast period owing to increased demand of pregnant women patients for feeding tubes.
Cancer care segment is expected to register a high CAGR
In terms of indications, the market is segregated into cancer care, nutrition deficiency, diabetes, orphan diseases, dysphagia, pain management, chronic kidney diseases, malabsorption/Gi disorder/diarrhea, alzheimer’s, and others. The cancer care segment held a key share of the market in 2020 and is expected to register a high CAGR during the forecast period owing to increased cancer incidences, which require nutritional support for patients. Meanwhile, the others segment is anticipated to expand at a rapid pace during the forecast period on account of increased development initiatives by key market players.
Home care segment is expected to grow at a healthy rate
Based on end-users, the global enteral feeding formulas market is divided into hospitals and home care. The hospitals segment is further categorized as cardiology, neurology, critical care, oncology, and others. The home care segment is expected to grow at a healthy rate during the forecast period due to the COVID-19 situation guidelines patients opted for home care. On the other hand, the hospitals segment is anticipated to constitute a major share of the market during the forecast period due to increase in number of patients for various diseases and adoption of treatment in hospitals.
North America is anticipated to constitute a key market share
In terms of regions, the global enteral feeding formulas market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is anticipated to constitute a key market share in the coming years due to rise in preference of home based treatments and growing burden of chronic diseases among a large number of patients in the region. On the other hand, the market of Asia Pacific is anticipated to expand at a significant growth rate during the forecast period owing to rising incidences of pre mature births, which is expected to fuel the demand for enteral feeding formulas. According to World Health Organization, China, India, Pakistan, Indonesia, and Nigeria are the top five countries with the highest number of pre matured births. Additionally, rising cases of children malnutrition in the region is expected to boost the regional market growth at a substantial rate.
Segments
Segments Covered in the Report
The global enteral feeding formulas market has been segmented on the basis of
Products
- Standard Formula
- Disease-Specific Formula
Flow types
- Intermittent Feeding Flow
- Continuous Feeding Flow
Stages
Indications
- Cancer Care
- Nutrition Deficiency
- Diabetes
- Orphan Diseases
- Dysphagia
- Pain Management
- Chronic Kidney Diseases
- Malabsorption/Gi Disorder/Diarrhea
- Alzheimer’s
- Others
End-users
- Hospitals
- Cardiology
- Neurology
- Critical Care
- Oncology
- Others
- Home Care
Regions
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- Danone SA
- Fresenius SE & Co. KGaA
- Nestlé
- Victus, Inc.
- Primus Pharmaceuticals, Inc.
- Meiji Holdings. Co., Ltd.
- Rickett Benckiser Group Plc.
Competitive Landscape
Key players competing in the global enteral feeding formulas market are Abbott; Danone SA; Fresenius SE & Co. KGaA; Nestlé; Victus, Inc.; Primus Pharmaceuticals, Inc.; Meiji Holdings. Co., Ltd.; and Rickett Benckiser Group Plc. Companies are collaborating with other players in the market for mergers and acquisitions and key players are largely investing in research and development activities to enhance their market position. For instance, Victus, Inc. launched ABINTRA Care, in 2020.
Request For Customization
Enquiry Before Buying
Speak With Analyst
